arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Scienture Holdings, Inc.

SCNX
$0.28 0.00 (-1.36%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
14 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
20
Health
Poor
Bearish
auto_awesome

Analytical Summary

Scienture Holdings, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $4.3M
Dividend Yield —
Revenue Growth 215.9% ↗
Op. Margin None
ROIC -58.0% ↘
FCF / Share $-0.87 ↗
Trailing P/E —
Price / Book 0.2x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Sep 23, 2026.

14-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$431.61K
↑ +215.9% —
Net Income Profit after all expenses
$-41.51M
↓ -557.9% —
Operating Margin Operating profit as % of sales
-87.8%
↓ -127.2% —
FCF / Share Free cash flow per share
$-0.87
↑ +79.4% —
Long-Term Debt Long-term obligations
$2.90M
↑ +1187.9% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓
14
Cash Quality ↓
33

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 14 years · 55 quarters